Welcome to our dedicated page for Simulations Plus SEC filings (Ticker: SLP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Simulations Plus, Inc. (Nasdaq: SLP) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including annual and quarterly reports, proxy statements, and current reports on Form 8‑K. As a California corporation in the professional, scientific, and technical services sector, Simulations Plus files with the U.S. Securities and Exchange Commission under file number 001‑32046.
Annual reports on Form 10‑K and quarterly reports on Form 10‑Q give detailed information on the company’s software and services segments, revenue mix, cost structure, research and development spending, and risk factors related to its biosimulation, cheminformatics, and consulting activities. These filings also describe the integration of AI/ML, PBPK, QSP/QST, and related modeling approaches that underpin its model‑informed and AI‑accelerated drug development offerings.
Proxy statements (DEF 14A) include information on board elections, auditor ratification, and equity incentive plans. For example, the company’s definitive proxy statement details proposals such as increasing shares authorized under the 2021 Equity Incentive Plan, board and committee structures, corporate governance practices, and executive compensation frameworks.
Current reports on Form 8‑K disclose material events such as changes in the independent registered public accounting firm, preliminary financial results and guidance, executive employment agreements, and scheduling of earnings releases and conference calls. These documents help investors understand governance decisions, auditor transitions, and key operational updates.
On Stock Titan, these filings are paired with AI‑powered summaries that highlight important points from lengthy documents, helping readers quickly identify items such as segment performance discussions, non‑GAAP reconciliations, equity plan amendments, and auditor changes. Users can also review filings related to compensation and equity awards, as well as other disclosures that shape the regulatory and governance profile of Simulations Plus.
Simulations Plus, Inc. is asking shareholders to vote at a virtual annual meeting on February 12, 2026. Shareholders of record on December 15, 2025, when 20,146,585 common shares were outstanding, can vote online, by phone, by mail, or during the webcast.
There are three key proposals. First, elect four directors: Dr. Daniel Weiner, Dr. Walter S. Woltosz, Dr. John K. Paglia, and Sharlene Evans. Second, ratify Rose, Snyder & Jacobs LLP as independent registered public accounting firm for the fiscal year ending August 31, 2026. The proxy explains prior changes between RSJ and Grant Thornton LLP and reports RSJ audit fees of $370,500 for 2025 and $479,500 for 2024.
Third, approve an amendment to the 2021 Equity Incentive Plan to increase shares reserved from 2,500,000 to 3,450,000. As of December 15, 2025, 2,568,762 shares were subject to outstanding awards and 410,131 shares remained available. The Board believes additional shares are needed to continue granting equity to employees, officers, directors, and service providers, and unanimously recommends voting FOR all three proposals.
Simulations Plus, Inc. entered into amended and restated employment agreements with its CEO, CFO, Chief Revenue Officer, and President of Service Solutions, and new agreements with its Co‑Chief Product & Technology Officer, COO, and Chief Scientific Officer, all effective December 2, 2025. The contracts set base salaries, performance‑based cash bonuses, and stock option targets under the company’s 2021 Equity Incentive Plan.
The CEO’s package includes a base salary of $547,700, a target cash bonus equal to 75% of salary, a target grant of 50,000 stock options, and potential additional discretionary cash and options. Other executives receive base salaries ranging from $283,100 to $359,100 with bonus targets of 25%–35% of salary and stock option targets of 15,000–20,000 options. If any covered executive is terminated without cause and signs a release, they are entitled to a one‑time payment equal to 12 months of base salary plus 12 months of COBRA health coverage paid by the company.
Simulations Plus (SLP) reported a Form 4 showing Director Lisa LaVange received 1,771 shares of common stock on 11/03/2025 as independent director compensation under the company’s 2021 Equity Incentive Plan at a stated price of $0. Following this grant, she beneficially owns 10,834 shares, held directly.
Simulations Plus (SLP): insider stock grant reported. A joint Form 4 shows a director and 10% owner acquired 1,771 shares of common stock on 11/03/2025 at $0, recorded as an “A” code transaction. The filing cites stock granted as independent director compensation under the 2021 Equity Incentive Plan.
Following the grant, the reporting person’s beneficial ownership is 3,288,002 shares, held directly. The form was filed by more than one reporting person.
Simulations Plus (SLP) reported an insider equity grant. Director Daniel L. Weiner acquired 1,771 shares of common stock on 11/03/2025 as a stock grant under the company’s 2021 Equity Incentive Plan.
The reported transaction was coded as an acquisition at a grant price of $0, reflecting independent director compensation. Following the grant, Weiner beneficially owned 12,654 shares, held directly.
Simulations Plus, Inc. (SLP) reported an insider transaction on Form 4. Director John Kenneth Paglia acquired 1,771 shares of common stock on November 3, 2025, described as “stock granted as independent director compensation” under the company’s 2021 Equity Incentive Plan.
The filing lists a transaction price of $0 per share for the grant. After this award, Paglia beneficially owned 10,696 shares, held directly.
Simulations Plus (SLP)1,771 shares of common stock at $0 as independent director compensation under the company’s 2021 Equity Incentive Plan.
Following the grant, Evans beneficially owns 13,280 shares, held directly. This filing reflects routine director compensation rather than an open‑market purchase.
Simulations Plus, Inc. (SLP) furnished an 8-K announcing a press release with preliminary operational results for its fourth fiscal quarter ended August 31, 2025, and providing guidance and estimates for the fiscal year ending August 31, 2026.
The information under Items 2.02 and 7.01, and Exhibit 99.1, is furnished and not filed, and is not incorporated by reference except as expressly stated. The company also included a customary caution regarding forward-looking statements.
Simulations Plus (SLP)50,000 stock options to purchase common stock at an exercise price of $16.02 per share on 10/16/2025. The options expire on 10/15/2035 and were reported as a direct holding following the transaction.
The award vests over three years: 40% on the first anniversary, then 30% on each of the second and third anniversaries. The filing reflects a routine compensation grant under which the number of derivative securities beneficially owned after the transaction is 50,000.
Simulations Plus (SLP) reported an insider equity grant: its EVP/CFO received 32,500 stock options at an exercise price of $16.02 on 10/16/2025.
The options expire on 10/15/2035 and vest in four equal annual installments, with one fourth vesting on each anniversary of the grant date. Following this grant, the reporting person holds 32,500 derivative securities directly.
FAQ
What is the current stock price of Simulations Plus (SLP)?
What is the market cap of Simulations Plus (SLP)?
